FORMULATION, OPTIMIZATION AND EVALUATION OF CELECOXIB LOADED CUBOSOME FOR TOPICAL DRUG DELIVERY SYSTEM

The present study is mainly focused to formulate the celecoxib loaded cubosomes. Celecoxib is [NSAID] medication used to treatment of pain and inflammation, associate with rheumatoid arthritis, and several other inflammatory disorder. Celecoxib shows poor solubility and poor bioavailability, to overcome the problems, Celecoxib is formulated as cubosomal gel. Pre-formulation studies were carried out, in this FTIR study results indicate there is no chemical interaction between drug and excipients. Eight different formulations (F1- F8) were prepared by Top -Down technique. Among the eight formulations, formulation (F7) was optimized, because of its high Entrapment efficiency (88.2%) and maximum percentage of drug release (89.69%) at the end of 8hrs compared to other formulations. The average particle size of cubosomal gel (F7) was found to be 488.21nm. The SEM images represent cubosomal gel (F7) are cubic in shape. From the In- vitro kinetics studies Formulation (F7) fitted with Higuchi release kinetics. Stability studies indicate that the cubosomal gel (F7) were stable during stability studies. Celecoxib loaded cubosomal gel may improve the bioavailability and solubility, So The celecoxib is suitable for the formulation of cubosomal gel.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-11-10
DOI
https://doi.org/10.5281/zenodo.17578121
Primary Topic
Pharmacology and Nanomedicine Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FORMULATION, OPTIMIZATION AND EVALUATION OF CELECOXIB LOADED CUBOSOME FOR TOPICAL DRUG DELIVERY SYSTEM

Zenodo (CERN European Organization for Nuclear Research)
Pharmacology and Nanomedicine Research
article

FORMULATION, OPTIMIZATION AND EVALUATION OF CELECOXIB LOADED CUBOSOME FOR TOPICAL DRUG DELIVERY SYSTEM

article en

Abstract

The present study is mainly focused to formulate the celecoxib loaded cubosomes. Celecoxib is [NSAID] medication used to treatment of pain and inflammation, associate with rheumatoid arthritis, and several other inflammatory disorder. Celecoxib shows poor solubility and poor bioavailability, to overcome the problems, Celecoxib is formulated as cubosomal gel. Pre-formulation studies were carried out, in this FTIR study results indicate there is no chemical interaction between drug and excipients. Eight different formulations (F1- F8) were prepared by Top -Down technique. Among the eight formulations, formulation (F7) was optimized, because of its high Entrapment efficiency (88.2%) and maximum percentage of drug release (89.69%) at the end of 8hrs compared to other formulations. The average particle size of cubosomal gel (F7) was found to be 488.21nm. The SEM images represent cubosomal gel (F7) are cubic in shape. From the In- vitro kinetics studies Formulation (F7) fitted with Higuchi release kinetics. Stability studies indicate that the cubosomal gel (F7) were stable during stability studies. Celecoxib loaded cubosomal gel may improve the bioavailability and solubility, So The celecoxib is suitable for the formulation of cubosomal gel.

Zenodo (CERN European Organization for Nuclear Research)
No poverty
Openalex Percentile: Top 29%
Pharmacology and Nanomedicine Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

FORMULATION, OPTIMIZATION AND EVALUATION OF CELECOXIB LOADED CUBOSOME FOR TOPICAL DRUG DELIVERY SYSTEM · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS